株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の液体生検市場:動向と予測

Global Liquid Biopsy Market by Products & Services, Sample, Application, End User and by Geography - Trends and Forecast to 2025

発行 Coherent Market Insights 商品コード 629580
出版日 ページ情報 英文 181 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.80円で換算しております。
Back to Top
世界の液体生検市場:動向と予測 Global Liquid Biopsy Market by Products & Services, Sample, Application, End User and by Geography - Trends and Forecast to 2025
出版日: 2018年01月10日 ページ情報: 英文 181 Pages
概要

当レポートでは、世界の液体生検市場について調査し、市場の概要と製品・サービス別、サンプル別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 調査目的と仮定

第2章 市場概要

第3章 市場動向、法規制、動向分析

  • 市場動向
  • PEST分析
  • ポーターズファイブフォース分析
  • 法規制シナリオ
  • 技術進歩
  • 合併・買収
  • パイプライン分析
  • 最近上市された製品

第4章 製品・サービス別

  • イントロダクション
  • 試薬・キット
  • 設備
  • サービス

第5章 サンプル別

  • イントロダクション
  • 無細胞DNA
  • 循環腫瘍細胞
  • エキソソーム

第6章 用途別

  • イントロダクション
  • 腫瘍検査
  • 非侵襲性出生前検査
  • 移植ケア

第7章 エンドユーザー別

  • イントロダクション
  • 病院
  • 研究試験所
  • 診断試験所
  • 患者

第8章 地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • アフリカ
  • 中東

第9章 競合環境

  • ヒートマップ分析
  • 企業プロファイル

第10章 セクション

目次

Liquid biopsy gained popularity among physicians owing to increasing importance of precision medicine and advantages offered by the liquid biopsy over conventional biopsy techniques. Clinical diagnosis of tumors is done by pathological testing and medical imaging in which pathological testing involves tissue biopsies, molecular pathology tests, and serological indicators tests. Among these techniques tissue biopsy is considered as a gold standard for diagnosis. However, it has certain disadvantages such as difficulty in obtaining tissues from terminal cancer patients, complications due to sampling, and result difference due to tumor heterogeneity. Liquid biopsy provides more accurate results and offers more advantages over conventional techniques. It uses circulating tumor cell detection and cell free DNA etc. techniques for early detection of the cancer.

Market Dynamics

Factors such as rising prevalence of various cancers, rising demand for minimally invasive procedures, and advantages offered by liquid biopsy over conventional tissue biopsy are supporting growth of the liquid biopsy market. Liquid biopsy offers advantages over conventional tissue biopsy such as early disease detection, real-time monitoring of the metastasis and actual treatment response, detection of primary tumors and metastasis through simple and non-invasive tests, and may be cheaper than conventional biopsy. Furthermore, prevalence of various cancers is increasing and according to National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer are diagnosed in the U.S., with an around 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2024, indicating need for early disease diagnosis and treatment. Demand for minimally invasive treatments is also increasing as tissue biopsy is an invasive approach for cancer diagnosis, wherein, liquid biopsy is more convenient, which is expected to boost growth of the liquid biopsy market.

Key features of the study:

This report provides in-depth analysis of liquid biopsy market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global liquid biopsy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key companies covered as a part of this study include Illumina, Inc., Roche AG, Natera, Inc., Laboratory Corporation of America Holdings (LabCorp), Qiagen N.V., Thermo Fisher Scientific Inc., Exact Sciences Corp., Biocept, Inc., Genomic Health, Inc., Guardant Health, TrovaGene Inc., CareDx Inc., Adaptive Biotechnologies Corporation, and Biocartis SA.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

The global liquid biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the liquid biopsy market

Detailed Segmentation:

  • Global Liquid Biopsy Market, By Products & Services:
  • Reagents & Kits     
  • Equipments
  • Services
  • Global Liquid Biopsy Market, By Sample:
  • Cell Free DNA (cfDNA)      
  • Circulating Tumor Cells (CTC)
  • Exosomes
  • Global Liquid Biopsy Market, By Application:
  • Oncology Testing
  • Noninvasive Prenatal Testing
  • Transplant Care     
  • Global Liquid Biopsy Market, By End User:
  • Hospitals     
  • Research Laboratories
  • Diagnostic Laboratories
  • Patients
  • Global Liquid Biopsy Market, By Geography:
  • North America
  • By Product & Services:
  • Reagents & Kits     
  • Equipments
  • Services
  • By Sample:
  • Cell Free DNA (cfDNA)      
  • Circulating Tumor Cells (CTC)
  • Exosomes
  • By Application:
  • Oncology Testing
  • Noninvasive Prenatal Testing
  • Transplant Care     
  • By End User:
  • Hospitals     
  • Research Laboratories
  • Diagnostic Laboratories
  • Patients
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Product & Services:
  • Reagents & Kits     
  • Equipments
  • Services
  • By Sample:
  • Cell Free DNA (cfDNA)      
  • Circulating Tumor Cells (CTC)
  • Exosomes
  • By Application:
  • Oncology Testing
  • Noninvasive Prenatal Testing
  • Transplant Care     
  • By End User:
  • Hospitals     
  • Research Laboratories
  • Diagnostic Laboratories
  • Patients
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product & Services:
  • Reagents & Kits     
  • Equipments
  • Services
  • By Sample:
  • Cell Free DNA (cfDNA)      
  • Circulating Tumor Cells (CTC)
  • Exosomes
  • By Application:
  • Oncology Testing
  • Noninvasive Prenatal Testing
  • Transplant Care     
  • By End User:
  • Hospitals     
  • Research Laboratories
  • Diagnostic Laboratories
  • Patients
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Product & Services:
  • Reagents & Kits     
  • Equipments
  • Services
  • By Sample:
  • Cell Free DNA (cfDNA)      
  • Circulating Tumor Cells (CTC)
  • Exosomes
  • By Application:
  • Oncology Testing
  • Noninvasive Prenatal Testing
  • Transplant Care     
  • By End User:
  • Hospitals     
  • Research Laboratories
  • Diagnostic Laboratories
  • Patients
  • By Country:
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East
  • By Product & Services:
  • Reagents & Kits     
  • Equipments
  • Services
  • By Sample:
  • Cell Free DNA (cfDNA)      
  • Circulating Tumor Cells (CTC)
  • Exosomes
  • By Application:
  • Oncology Testing
  • Noninvasive Prenatal Testing
  • Transplant Care     
  • By End User:
  • Hospitals     
  • Research Laboratories
  • Diagnostic Laboratories
  • Patients
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product & Services:
  • Reagents & Kits     
  • Equipments
  • Services
  • By Sample:
  • Cell Free DNA (cfDNA)      
  • Circulating Tumor Cells (CTC)
  • Exosomes
  • By Application:
  • Oncology Testing
  • Noninvasive Prenatal Testing
  • Transplant Care     
  • By End User:
  • Hospitals     
  • Research Laboratories
  • Diagnostic Laboratories
  • Patients
  • By Country:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Roche AG *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Illumina, Inc.
  • Natera Inc.
  • Laboratory Corporation of America Holdings
  • Qiagen N.V.
  • Thermo Fisher Scientific
  • Exact Sciences Corp.
  • Biocept, Inc.
  • Genomic Health, Inc.
  • Guardant Health
  • CareDx Inc.
  • Adaptive Biotechnologies Corporation
  • Biocartis SA.
  • “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Products & Services
    • Market Snippet, By Sample
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Regulatory Scenario
  • Technological Evolution
  • Mergers & Acquisition
  • Pipeline Analysis
  • Recently Launched Products

4. Global Liquid Biopsy Market, By Products & Services, 2017-2025 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2017-2025
    • Segment Trends
  • Reagents & Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
  • Equipments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)

5. Global Liquid Biopsy Market, By Sample, 2017-2025 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2017-2025
    • Segment Trends
  • Cell Free DNA (cfDNA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
  • Circulating Tumor Cells (CTC)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
  • Exosomes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)

6. Global Liquid Biopsy Market, By Application, 2017-2025 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2017-2025
    • Segment Trends
  • Oncology Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
  • Noninvasive Prenatal Testing (NIPT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
  • Transplant Care
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)

7. Global Liquid Biopsy Market, By End User, 2017-2025 (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, 2017-2025
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
  • Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
  • Patients
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)

8. Global Liquid Biopsy Market, By Regions, 2017-2025 (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2016 and 2025 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2025
  • North America
    • Market Size and Forecast, By Products & Services, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Sample, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Products & Services, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Sample, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Products & Services, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Sample, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Market Size and Forecast, By Products & Services, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Sample, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Products & Services, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Sample, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
    • Central Africa
    • South Africa
    • North Africa
  • Middle East
    • Market Size and Forecast, By Products & Services, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Sample, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Application, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By End User, 2017-2025 (US$ Mn)
    • Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East

9. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Roche AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Illumina, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Natera Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Laboratory Corporation of America Holding
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Qiagen N.V.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Thermo Fisher Scientific
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Exact Sciences Corp.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Biocept, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Genomic Health Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Guardant Health
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • CareDx Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Adaptive Biotechnologies Corporatio
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Biocartis SA.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top